Information Library

Results for: Lower portfolio & investment risks - Partnership Structures

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Partnering to Maximize Rewards in Pharmerging Markets

White Paper — September 15, 2011
In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending.
The New Health Alliance

White Paper — January 10, 2011
Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders.
Capital - sharing risks, expanding opportunities

Brochure — July 14, 2010
This Capital brochure reviews how Quintiles helps biopharma allies maximize the value of assets, reduce risk, accelerate outcomes and increase rewards.
QUINTILES AND ALLERGAN ANNOUNCE CO-PROMOTION AGREEMENT

Press Release — September 25, 2009 – Quintiles Transnational Corp. and Allergan, Inc. announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR®.

Page 1 of 1 (4 results)